Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors
Clinical trial NCT00042809 · COMPLETED
Trial details
- NCT number
- NCT00042809
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2007-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.